NEUROLOGICAL RESEARCH, published by TAYLOR & FRANCIS LTD, is a distinguished journal focusing on the diverse and evolving field of neurology. Established in 1979, this journal has been a prominent platform for disseminating groundbreaking research and clinical advances up to 2024. With an ISSN of 0161-6412 and an E-ISSN of 1743-1328, it offers valuable insights for researchers, professionals, and students interested in the intricate workings of the nervous system. The journal holds a respectable Q2 ranking in the field of Medicine (miscellaneous) and Q3 in the categories of Neurology and Clinical Neurology, reflecting its commitment to high-quality research. Although NEUROLOGICAL RESEARCH does not currently offer an open access option, its contributions to the literature are vital for fostering advancements in neurological understanding and treatment. With an engaged readership and a mission to advance scientific knowledge, NEUROLOGICAL RESEARCH serves as a crucial resource for anyone dedicated to neurological health and innovation.

The Journal of Brachial Plexus and Peripheral Nerve Injury, published by THIEME MEDICAL PUBL INC, is a leading open-access journal dedicated to the field of neurology, specifically focusing on injuries related to the brachial plexus and peripheral nerves. Since its inception in 2006, the journal has provided a platform for researchers, clinicians, and students to share cutting-edge studies and advancements within this specialized area of neurology. With an impact factor that underscores its relevance in the academic community, the journal is categorized in the Q4 quartile for both Neurology and Clinical Neurology in 2023. The journal aims to foster collaboration and innovation among professionals by presenting rigorous research findings, clinical studies, and reviews that enhance the understanding and management of nerve injuries. Published from the United Kingdom, the journal facilitates global access to important knowledge, encouraging contributions that will further the discourse in this critical field of medicine.

AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, published by Elsevier, stands as a pivotal journal in the fields of Cellular and Molecular Neuroscience, Endocrine and Autonomic Systems, and Neurology (Clinical), boasting an impressive Q2 ranking in the latter two categories as of 2023. This journal, which has been in circulation since 2000, provides a vital platform for disseminating innovative research pertaining to the autonomic nervous system's fundamental and clinical aspects, thus addressing significant challenges in both theoretical understanding and clinical application. Researchers and practitioners worldwide find value in its comprehensive articles, reviews, and case studies that explore the intricacies of autonomic neurobiology. As part of Elsevier's prestigious portfolio, the journal offers options for Open Access, enhancing the visibility and accessibility of its content. With an increasing impact on clinical practices and research directions, AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL serves as an essential resource for advancing knowledge and fostering collaboration among scholars, clinicians, and students dedicated to unraveling the complexities of the autonomic nervous system.

NEUROMODULATION is a premier academic journal dedicated to advancing the fields of anesthesiology, pain medicine, and neurology. Published by Elsevier, this prestigious journal has consistently maintained a high impact factor, reflecting its relevance and influence in the medical community. With a commendable track record spanning from 1998 to 2024, NEUROMODULATION is classified in the Q1 quartile for both Anesthesiology and Pain Medicine and Medicine (miscellaneous), demonstrating its excellence among top-tier journals. Additionally, it ranks in the Q2 quartile for Neurology and Clinical Neurology, showcasing a broad appeal across multiple disciplines. The journal's substantial Scopus rankings—22nd out of 136 in Anesthesiology and Pain Medicine and 93rd out of 400 in Clinical Neurology—underscore its critical role in disseminating cutting-edge research and clinical findings. NEUROMODULATION endeavors to provide a robust platform for researchers, clinicians, and students to explore innovative therapeutic approaches and the complexities of neural modulation, ultimately contributing to improved patient outcomes and advancing the state of medical science.

Diabetes & Vascular Disease Research is a leading academic journal dedicated to advancing the understanding and treatment of cardiovascular and metabolic diseases, particularly diabetes. Published by SAGE Publications Ltd in the United Kingdom, this journal serves as a key resource for researchers, clinicians, and students seeking to explore the intricate relationship between diabetes and vascular health. With an impressive Impact Factor and ranked in the Q2 quartile in prominent categories such as Cardiology, Endocrinology, and Internal Medicine, the journal provides a platform for high-quality, peer-reviewed research. Covering a broad range of topics from pathophysiology to therapeutic innovations, Diabetes & Vascular Disease Research plays a vital role in shaping contemporary discourse in the field. With contributions from leading experts and a commitment to disseminating valuable findings, this journal is a must-read for anyone involved in the fight against vascular complications arising from diabetes.

Pain Research & Management, published by HINDAWI LTD, is a leading academic journal that serves as a vital resource for researchers, clinicians, and students in the fields of anesthesiology, pain medicine, and neurology. With an impressive impact factor and categorized in the second quartile (Q2) for both anesthesiology and neurology as of 2023, the journal features high-quality, peer-reviewed research articles that address the complexities of pain management. Established in 1996 and recognized as Open Access, this journal allows unrestricted access to groundbreaking studies, thereby facilitating knowledge dissemination and collaboration within the global scientific community. With a strong ranking—34/136 in anesthesiology and 72/192 in neurology—Pain Research & Management retains a well-deserved reputation for publishing innovative and authoritative content that significantly contributes to the advancement of pain research and clinical practice. Researchers and healthcare professionals alike will find this journal indispensable for staying abreast of the latest discoveries and best practices in pain management.

Welcome to the Journal of Central Nervous System Disease, a premier Open Access publication dedicated to advancing the understanding of neurological disorders and their underlying mechanisms. Published by SAGE Publications Ltd, this esteemed journal has been serving the scientific community since 2009 and is committed to disseminating high-quality research that spans from clinical neurology to cellular and molecular neuroscience. With an impressive impact factor, the journal ranks within the top quartiles—Q2 in both Neurology and Clinical Neurology, and Q3 in Cellular and Molecular Neuroscience as of 2023. The journal's indexing in Scopus reflects its significant contribution to the field, being ranked #83 out of 400 in clinical neurology and #38 out of 97 in cellular and molecular neuroscience. This essential resource, based in the United States, is crucial for researchers, clinicians, and students looking to stay at the forefront of neurological science. By providing Open Access options, we ensure that groundbreaking research is readily available to a global audience, fostering collaboration and innovation in the study of central nervous system diseases.

Neurology-Neuroimmunology & Neuroinflammation, published by LIPPINCOTT WILLIAMS & WILKINS, stands at the forefront of research in the rapidly evolving fields of neurology and neuroimmunology. Since its inception in 2014, this prestigious journal has embraced an Open Access model, ensuring that groundbreaking findings are readily available to researchers, clinicians, and students worldwide. Covering a broad spectrum of topics related to neuroinflammation, the journal has gained a remarkable reputation, attaining a Q1 ranking in both Neurology and Neurology (clinical) as of 2023, and ranking #6 out of 192 in the neuroscience category on Scopus. The journal's commitment to high-quality research aims to facilitate the understanding of neurological disorders, promote innovative therapies, and inspire collaboration among professionals. Addressing critical issues at the intersection of neurology, immunology, and clinical practice, Neurology-Neuroimmunology & Neuroinflammation is an essential platform for the dissemination of knowledge and the advancement of this vital field.

Pain Reports, published by LIPPINCOTT WILLIAMS & WILKINS, is a premier open access journal dedicated to advancing the field of anesthesiology and pain medicine. With an impressive impact factor and a ranking of #15 out of 136 in its category, this journal is recognized within the 89th percentile of its field as of 2023. Since its launch in 2016, Pain Reports has provided a vital platform for researchers, clinicians, and professionals to disseminate and access high-quality research articles, reviews, and case studies focused on the multifaceted aspects of pain management and treatment. Through its commitment to open access, the journal ensures that cutting-edge findings are readily available to a global audience, facilitating collaboration and knowledge sharing. With its scope continually evolving until 2024, Pain Reports strives to address the critical and emerging challenges in pain research, making it an essential resource for individuals dedicated to improving patient outcomes and advancing scholarly discourse in pain management.

ACTA NEUROPATHOLOGICA, published by Springer, is a leading journal in the fields of cellular and molecular neuroscience, clinical neurology, and pathology, recognized for its exceptional quality and impactful research. With an impressive impact factor and currently ranked in the Q1 tier across multiple categories in 2023, this journal serves as a premier platform for the dissemination of groundbreaking findings in neuropathology. The journal's robust Scopus rankings highlight its influence, standing at #2 in Pathology and Forensic Medicine and #5 in Clinical Neurology. Since its inception in 1961, ACTA NEUROPATHOLOGICA has provided crucial insights into neurological diseases and disorders, contributing significantly to the advancement of medical science. Aimed at researchers, practitioners, and students alike, this journal fosters a deeper understanding of neurological conditions and encourages innovative approaches within the field. It is essential reading for anyone dedicated to unraveling the complexities of the nervous system.